You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone

Article metrics

Article menu

Download PDFPDF

Case Report
Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019550
Jan 202015151
Feb 202018183
Mar 202048484
Apr 202017170
May 202035357
Jun 202031316
Jul 202023234
Aug 2020191913
Sep 202038381
Oct 202034342
Nov 202034335
Dec 202025253
Jan 2021212112
Feb 202128286
Mar 2021252516
Apr 202124247
May 202116164
Jun 202117172
Jul 202135354
Aug 2021553
Sep 202125254
Oct 202118183
Nov 202121216
Dec 202132335
Jan 202231322
Feb 202228280
Mar 2022333811
Apr 202232355
May 202248503
Jun 202232323
Jul 202226296
Aug 202244444
Sep 202248483
Oct 202240411
Nov 2022363814
Dec 202239393
Jan 202330301
Feb 202346472
Mar 202337417
Apr 202319198
May 202315154
Jun 202319193
Jul 202328287
Aug 202329294
Sep 202313130
Oct 202323233
Nov 202317176
Dec 202319197
Jan 2024202113
Feb 202422225
Mar 2024444512
Apr 202423245
May 202423236
Jun 202444434
Jul 2024646511
Aug 202419186
Sep 202432325
Oct 2024363714
Nov 2024394010
Dec 202432328
Jan 2025232412
Feb 202527278
Mar 202541417
Apr 202543438
May 202522228
Jun 2025313112
Jul 2025110
Total19271954382